The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients

Key Points

• This research aims to explore the association between erythropoietin gene polymorphism and retinopathy risk in individuals with type 2 diabetes mellitus.
• Analysis of polymorphism rs1617640 in T2DM patients.
• Assessment of retinopathy prevalence among subjects.
• Statistical evaluation of genotype-phenotype associations.
• EPO rs1617640 polymorphism significantly increases the risk of developing diabetic retinopathy.
• Findings suggest genetic influence on microvascular complications in type 2 diabetes.